Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours Β· Estimated delivery Sep 12 - Sep 17
You may benefit from a longer initial treatment course, a more gradual taper, or a commitment to maintenance dosing rather than complete discontinuation
.png)
Clear safeguards and balanced messaging are critical to maintaining trust among patients, providers, and regulators
If you're building a routine around better absorption, the Knowledge Center can help you explore related ingredients and formulas
Phase 2: The Study That Started the Hype (NEJM, 2023) The Phase 2 trial was published in The New England Journal of Medicine one of the most respected medical journals in the world
The SURPASS-4 trial showed that tirzepatide was associated with reduced progression of albuminuria compared to insulin glargine in patients with type 2 diabetes, suggesting potential kidney benefits
Consider how much ongoing contact you want with your healthcare provider
